Jacques Näsström

Jacques Näsström worked as the Chief Executive Officer at Accuro Immunology AB. He then served as the Director of Cellular & Molecular Pharmacology at Astra AB from 1986 to 2001.
Dr. Näsström also held the position of Director at Cellectricon AB. From 2006 to 2010, he worked as the Research Director at Q-Med AB. He was also the Director at Independent Pharmaceutica AB. Prior to that, Dr. Näsström worked as an Investment Manager at Karolinska Investment Fund KB from 2001 to 2006.
He also served as the Principal at AngioGenetics AB. Currently, he is the Chief Scientific Officer & Vice President at Egetis Therapeutics AB, a position he has held since 2017.
In terms of education, Dr. Näsström holds an MBA from Stockholm School of Economics and a doctorate from the University of Uppsala.